LOUISVILLE, Ky. / Oct 01, 2024 / Business Wire / Leading health and well-being company Humana Inc. (NYSE: HUM) today announced its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2025.
Humana’s plans are tailored to meet the varying needs of Medicare beneficiaries, providing them with affordable options during the upcoming Medicare Advantage Annual Election Period (AEP) Oct. 15-Dec. 7. During this time, Medicare beneficiaries can review changes to their current plan and determine if the plan still meets their needs for the next year.
“Our members want benefits that work for their lives, which is why we don’t view Medicare Advantage as a one-size-fits-all option,” said George Renaudin, Humana’s President of Medicare and Medicaid. “Our members have told us what benefits really matter to them. We listened and created affordable health plans that offer high-quality care and align with what they want and need.”
Based on member feedback, Humana is including coverage for new glasses every year in every plan with a vision benefit. Humana also is offering plans with comprehensive dental coverage that includes deep cleanings, fillings and crowns in nearly every county it serves.
Humana has a total of 793 individual Medicare Advantage plans throughout the country for 2025, offering people the ability to choose a plan that fits their budget and lifestyle. Highlights include:
All plans that provide coverage for prescription drugs, whether it’s part of a Medicare Advantage Prescription Drug plan or a stand-alone Part D Prescription Drug Plan, will see some benefit enhancements in 2025 under the Inflation Reduction Act. Members with Part D coverage will now have a $2,000 cap on out-of-pocket drug costs, and they will no longer have a coverage gap (donut hole) phase – simplifying payments and making prescription drug costs more predictable and affordable.
Humana’s stand-alone Part D Prescription Drug Plans are designed for individuals who enroll in Original Medicare and need medications covered. Updates to Humana Prescription Drug Plan benefits for 2025 include:
In 2025, Humana will have Medicare Advantage plan offerings in 48 states, plus Washington, D.C., and Puerto Rico, covering 89% of U.S. counties.
In total, Humana is expanding its Medicare HMO offerings into 12 new counties and its Medicare Advantage LPPO plans in 17 new counties. The following plans will be available in new states for the first time:
All Humana Medicare Advantage and Prescription Drug Plan members have the option to use CenterWell Pharmacy, a home delivery pharmacy that helps customers manage their prescription and over-the-counter medications with convenient, safe and on-time deliveries by mail to their front doorsteps or locations of their choice.
Humana has served Medicare beneficiaries for decades, with more than 8.5 million Medicare members as of June 30, 2024. More than 5.6 million of those members are enrolled in a Medicare Advantage plan.
For More Information. Humana offers in-person, online and telephone enrollment options. All enrollment options will connect Medicare beneficiaries with a licensed sales agent. For information about Humana’s Medicare plan options available in your area, visit Humana.com/Medicare or call toll-free 1-800-706-1368 (TTY: 711). Licensed sales agents are available 8 a.m. to 8 p.m. local time, seven days a week. Spanish language resources are available here.
About Humana
Humana Inc. (NYSE: HUM) is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we strive to make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.
Additional Information
Humana is a Medicare Advantage HMO, PPO, and PFFS organization and a stand-alone PDP prescription drug plan with a Medicare contract. Humana is also a Coordinated Care HMO SNP, PPO SNP plan with a Medicare contract and a contract with the state Medicaid program. Enrollment in any Humana plan depends on contract renewal. Other providers are available in the Humana network. Allowance amounts cannot be combined with other benefit allowances. Limitations and restrictions may apply. Members who do not receive Extra Help are not eligible. Extra Help requirements do not apply to Puerto Rico DSNPs. The Part B Giveback Benefit pays part or all of your Part B premium and the amount may change based on the amount you pay for Part B.
The Humana USAA Honor Giveback plans are available to anyone eligible for Medicare and veterans should consider all of their health plan options. According to monthly enrollment by plan data from CMS accessed on 7/16/24, Humana leads the industry with 53% of market share within the veteran branded MA-only plans.
The Humana Premier RX Plan (PDP) and the Humana Value RX Plan (PDP) Prescription Drug Plan pharmacy networks include limited lower-cost, preferred pharmacies in urban areas of AR, CT, DE, IA, IN, KY, MA, MI, MN, MO, ND, NJ, NY, OH, RI, SD, TN, WI, WV; suburban areas of AZ, CT, DE, HI, IN, MA, MI, MN, MT, ND, NJ, NY, OH, PA, PR, RI, WI, WV; and rural areas of AK, IA, MN, MT, ND, NE, SD, VT, WY. There are an extremely limited number of preferred cost share pharmacies in urban areas in the following states: DE, MI, MN, ND; suburban areas of MT and ND; and rural areas of ND. The lower costs advertised in our plan materials for these pharmacies may not be available at the pharmacy you use. For up-to-date information about our network pharmacies, including whether there are any lower-cost preferred pharmacies in your area, please call Customer Care at 1-800-281-6918 (TTY: 711) or consult the online pharmacy directory at Humana.com.
Humana received the highest CX Index™ score among health insurers in Forrester’s proprietary 2024 Customer Experience Benchmark Survey. The proprietary survey results are based on consumers’ opinions of their experiences with the brands in the survey. Forrester Research does not endorse any company included in any CX Index report and does not advise any person to select the products or services of any particular company based on the ratings included in such reports.
Last Trade: | US$257.77 |
Daily Change: | -3.32 -1.27 |
Daily Volume: | 1,495,109 |
Market Cap: | US$31.040B |
October 24, 2024 October 23, 2024 August 19, 2024 August 08, 2024 July 31, 2024 |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREC4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB